Various neurodegenerative disorders are believed to be associated with deficiencies in GVIA iPLA2 expression [41], including infantile neural axonal dystrophy, atypical neural axonal dystrophy, and adult-onset dystonia Parkinson's disease. This evidence concerns the gene PLA2G6 and Parkinson disease.